Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition

Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition

  • June 2021 •
  • 55 pages •
  • Report ID: 6103613 •
  • Format: PDF
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition

Summary
This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Scope
This 55-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends.

This report is required reading for -
- CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
- Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
- Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking

Reasons to Buy
- Overview of M&A in the Pharma CMO Industry
- Detailed view of CDMO performance by number of deals completed from Deals database
- Analysis of the M&A of specific manufacturing services
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.